Skip to main content
. 2015 Jan 26;7(1):35–40. doi: 10.5114/jcb.2015.48539

Table 2.

Patient/tumor characteristics and univariate log-rank results for overall (OS) and relapse-free survival (RFS)

Characteristic OS, p-value RFS, p-value
Age (≥ 70 vs. < 70) 0.062 0.132
Race (Caucasian vs. other) 0.716 0.388
Obese (BMI ≥ 30 vs. < 30) 0.249 0.281
Smoking history 0.008 0.076
Oral contraceptive history 0.634 0.182
History of hormone replacement therapy 0.575 0.226
Family history of cancer 0.502 0.579
Histology (pure USC vs. mixed) 0.168 0.551
Endocervical glandular involvement 0.530 0.278
Endocervical stromal involvement 0.450 0.768
Myometrial invasion (≥ 50% vs. < 50%) 0.001 < 0.0001
Lymph-vascular space invasion 0.971 0.003
Lower uterine segment involvement 0.388 0.551
Cytology positive 0.716 0.587